Weiguang Biotech announced that the sixth meeting of the fourth board of directors of the company agreed to increase the capital of its subsidiary Wanning Pulp Station and Ankang Pulp Station by 15 million yuan and 40 million yuan respectively in cash. There is no need to submit it to the shareholders' meeting for review, and it is not a major asset restructuring or related transaction. Wanning Pulp Station is a wholly-owned subsidiary of the company. Ankang Pulp Station Company holds 80% of the shares, while another shareholder, Xia Yuzhen, relinquished the capital increase. After the capital increase, the registered capital of Wanning Pulp Station rose to 20 million yuan, and the company held 100% of the shares; the registered capital of Ankang Pulp Station rose to 19.742 million yuan, and the company held 91.65% of the shares. This capital increase is to speed up the construction of pulping stations, etc., and will not affect the scope of consolidated statements and the normal operation of the company.

Weiguang Biotech announced that the sixth meeting of the fourth board of directors of the company agreed to increase the capital of its subsidiary Wanning Pulp Station and Ankang Pulp Station by 15 million yuan and 40 million yuan respectively in cash. There is no need to submit it to the shareholders' meeting for review, and it is not a major asset restructuring or related transaction. Wanning Pulp Station is a wholly-owned subsidiary of the company. Ankang Pulp Station Company holds 80% of the shares, while another shareholder, Xia Yuzhen, relinquished the capital increase. After the capital increase, the registered capital of Wanning Pulp Station rose to 20 million yuan, and the company held 100% of the shares; the registered capital of Ankang Pulp Station rose to 19.742 million yuan, and the company held 91.65% of the shares. This capital increase is to speed up the construction of pulping stations, etc., and will not affect the scope of consolidated statements and the normal operation of the company.